...scenario of the pharmaceutical industry in Bangladesh. In Bangladesh, the pharmaceutical sector is one of the most developed hi-tech sectors, which is contributing in the country’s economy. After promulgation of Drug Control Ordinance -1982, the development of this sector was accelerated. The professional knowledge, thoughts and innovative ideas of the pharmaceutical professionals working in this sector are the key factors for this development. Due to resent development of this sector, it is exporting medicines to global markets including highly regulated European markets. This sector also providing 97% of the total medicine requirement of the local market. Leading pharmaceutical companies are expanding their business with the aim to expand export market recently few new companies have been established with hi-tech equipments and high professionals which will enhance the strength of this sector. Government declared “Pharmaceuticals as the product of the year (2008), in a bid to boost it export further, such a move is the first in Bangladesh and pharmaceuticals has been single out considering its tremendous prospect in the global market and diversification of basket as well as Bangladesh pharmaceuticals industry is the highest among the LDCs and growing with 50% annually. Bangladesh pharmaceuticals industry is one of the first growing sector in Bangladesh among the 50 LDCs. Bangladesh is the only country that is nearly self sufficient in pharmaceuticals sector. Acknowledgement...
Words: 2796 - Pages: 12
...Pharmaceutical Sector of Bangladesh The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. Manufacturers produce insulin, hormones, and cancer drugs. This sector provides 97% of the total medicinal requirement of the local market. The industry also exports medicines to global markets, including Europe. Pharmaceutical companies are expanding their business with the aim to expand the export market. History Right after liberation war three fourth of the pharmaceutical industries was dominated by multinational companies. The National Drug Policy (NDP) in 1982 and 2005 has major impact in the development and growth of the Bangladesh pharmaceutical industry. Key points of National Drug Policy of 1982 To provide administrative and legislative support for ensuring quality of essential drugs which are relevant to the national health need. To reduce the price of medicine by ensuring the lowest competitive price. To eliminate non-essential medicine from the market To promote production of local drug and raw materials. To develop proper drug monitoring and information system to prevent wasteful misuse and to ensure the proper utilization of the drugs. To ensure GMP and qualified pharmacist in manufacturing companies. Drug Regulatory Authorities in Bangladesh • The Directorate General of Drug Administration (DGDA) • The Pharmacy Council of Bangladesh (PCB) Local Market Overview The Bangladesh...
Words: 998 - Pages: 4
...Introduction: The pharmaceuticals sector is one of the potential as well as capital oriented sectors in Bangladesh. The pharmaceutical industry in Bangladesh is also one of the most developed sectors within the country's economy. Pharmaceutical industry is technologically the most developed manufacturing industries in Bangladesh and the third largest industry in terms of contribution to government’s revenue. The industry contributes about 1% of the total GDP. The pharmaceuticals market is almost self-sufficient in meeting local demand as 97% of the drugs are manufactured locally while the remaining 3% are imported from abroad. The industry manufactured about 5,600 brands of medicines in different dosage forms. Due to recent development of this sector we are exporting medicines to global market including European market. Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh .The Company was founded in 1958 by Samson H. Chowdhury along with three of his friends as a private firm. It was converted into a public limited company in 1991. It is engaged in the manufacturing of branded generic pharmaceutical products and also other ethical drugs and medicines. The company formulation facilities include Pabna Unit, Dhaka Unit, Pesticide Unit, Cephalosporin Unit and Animal Health Unit. Square Pharmaceuticals Limited has extended its range of services towards the highway of global market. It pioneered exports of medicines from Bangladesh in 1987 and has been...
Words: 4423 - Pages: 18
...Concurrent Events : 2011 DHAKA, BANGLADESH 24-26 FEBRUARY-2011 The 8th International Exhibition on Asian Pharmaceutical Industries THE GATEWAY TO THE SOUTH ASIAN PHARMA MARKET Join with Expected Exhibiting Companies 450 Over Trade Professionals 9000 On sq. mt. Floor-space 8500 From Countries 28 VENUE : Bangabandhu International Conference Centre, Dhaka. Bangladesh ORGANISED BY SUPPORTED BY Bangladesh Association of Pharmaceutical Industries Bangladesh Aushad Shilpa Samity OFFICIAL ONLINE MEDIA If South Asia is your market, APE 2011 is your show www.asiapharma.org 2011 DHAKA, BANGLADESH 24-26 FEBRUARY-2011 Bangladesh Association of Pharmaceutical Industries Bangladesh Aushad Shilpa Samity ORGANIZING COMMITTEE CHAIRMAN Mr. Salman F Rahman PRESIDENT'S MES SAGE Vice-Chairman, Beximco Group CONVENOR Mr. Adbul Muktadir We, Bangladesh Association of Pharmaceutical Industries (Bangladesh Aushad Shilpa Samity) are delighted to inform you about the forthcoming international exhibition on South Asian Pharmaceutical industry – ASIA PHARMA EXPO- 2011 to be held in Dhaka from 24 to 26 February 2011. The South Asian Pharmaceutical market is currently experiencing unprecedented growth and as a result the ASIA PHARMA EXPO provides unlimited opportunity to all related business and trade professionals. In all our previous Asia Pharma Expo events, the participants from neighboring countries and other parts of the world...
Words: 3538 - Pages: 15
...(UNCTAD/WTO), Bangladesh market size for pharmaceuticals and natural products was US$ 517 million and the total herbal medicine was about US$ 50 million in 2004. Local companies satisfied 95% of domestic demand with a 10% contribution from multinational companies. The number of companies was subdivided into pharmaceutical units (232), ayurvedic, homeopathic, biochemic units (308), and herbal and unani-related units (295). The pharmaceutical sector was the second largest sector (after agriculture) in terms of national revenue. Employment in the sector was about 75,000. The value of export for essential drugs was US$ 3.1 million and natural ingredients US$ 48 thousand. It exported drugs to over 50 countries in the world, but mainly to Bhutan, Singapore and Yemen. The export market is on a rise each year. On the other hand, Bangladesh imported essential drugs worth of US$ 21.6 million and natural ingredients of US$ 19 million. Types of products imported included 700 different types of finished products and over 742 basic raw materials. 85% of raw materials are imported from West European countries, USA, Pakistan, Japan, Korea, Singapore, China and India. Importance of the study: Now-a-days, Pharmaceuticals Company is one of the largest industries in the world contributing 13.29% of global GDP. The study helps us gain hands on knowledge in the Pharmaceuticals sector in Bangladesh. The study has enormous implication to develop the appropriate Pharmaceuticals policy, to incorporate...
Words: 7010 - Pages: 29
...growing pharmaceutical sector The export value of pharmaceuticals is growing at a reasonable rate every year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007 and posted further gains last year. Export destinations are also increasing in number. Beginning in the 1950s, when a few multinationals and local entrepreneurs set up manufacturing facilities in the then East Pakistan, now over 200 companies produce now medicines in Bangladesh. The pharmaceutical industry in Bangladesh has otherwise the potential to grow and enjoy a number of competitive advantages. Quality assurance has put the industry on a solid base. Almost all companies follow the World Health Organisation (WHO) Good Manufacturing Practice (GMP) standards. Bangladesh’s strict quality compliance gives pharmaceuticals an advantage to compete with producers in India, China, Brazil and Turkey in the overseas export markets. The capability of the industry has helped it achieve excellence as per the general international standards. A good number of local pharmaceutical companies have won accreditation from the overseas regulatory authorities including some of those in the developed countries. Two such local companies have been accredited by EMEA (Austria) and the Therapeutic Goods Administration (TGA-Australia). The accreditation facilitates their entry into the lucrative market as reputed players. Bangladesh’s national drug policy requires strict standards compliance from the pharmaceutical manufacturers...
Words: 686 - Pages: 3
...conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. SQUARE today is more than just an organization, it is an institute. In a career spanning across four and half decades it has pioneered the development of the local business in fields as diverse as Pharmaceuticals, Toiletries, Garments, Textile, Information Technology, Health Products, Food Products, Hospital, etc. With an average Annual turnover of over US$ 200 million and a workforce of about 3500 the SQUARE Group is a true icon of the Bangladesh business sector. Vision satement We view business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization. Mission statement Our Mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large. Chapter B: Company Profile History of Square Group 1958 : | Debut of Square Pharma as a Partnership Firm. | 1964 : | Converted into a Private Limited Company. | 1974 : | Technical Collaboration with Janssen Pharmaceutical, Belgium, a subsidiary...
Words: 5298 - Pages: 22
...industry | 2.1 | Introduction | 7 | 2.2 | Pharmaceutical sector in Bangladesh | 7 | 2.3 | Market size and growth | 8 | 2.4 | Major players | 11 | 2.5 | Underlying threat | 12 | 2.6 | Pricing of drug | 13 | 2.7 | Regulatory authorities | 14 | | Chapter-3: Overview of the organization | 3.1 | Company profile | 15 | 3.2 | Strategic analysis | 17 | 3.3 | Policies | 19 | 3.4 | Overview of the ACI Pharmaceuticals | 24 | 3.5 | Services | 28 | 3.6 | Products | 29 | 3.7 | Market | 32 | 3.8 | Distribution | 32 | 3.9 | Future plan | 33 | 3.10 | SWAT analysis of ACI Pharmaceuticals | 34 | 3.11 | Organogram | 35 | Chapter-4: Analysis of Business Potentiality in Urban and Market Position | 4.1 | Market share of ACI Pharmaceuticals | 37 | 4.2 | Growth of ACI Pharmaceuticals | 38 | 4.3 | Potential business sectors for ACI Pharmaceuticals | 39 | 4.4 | Strategies taken by ACI Pharmaceuticals | 42 | 4.5 | Key Challenges | 44 | | Chapter-5: Recommendation & conclusion | 5.1 | Recommendation | 46 | 5.2 | Conclusion | 47 | 5.3 | Bibliography | 48 | 5.4 | Appendix | 49 | Executive Summary Pharmaceutical is one of the leading export earning sectors in Bangladesh. The economy is mostly depended on export earning since it facilitates the increase in export earning of the country. So it has a potential market for growing out. This report “Business Potentiality of ACI Pharmaceuticals in Urban, is prepared based on the information...
Words: 572 - Pages: 3
...Historical Background Incepta Pharmaceuticals Ltd. is a leading pharmaceutical company in Bangladesh established in the year 1999. The company has a very big manufacturing facility located at Savar, 35 kilometer away from the center of the capital city Dhaka. Incepta began its operation with a handful of highly skilled and dedicated professionals guided by an able leadership. Proper strategic planning, technical excellence, swift and timely decisions helped us achieve our objectives leading to much faster growth. Incepta was able to anticipate the need of the market and provide the right product at the right time. High focus on R&D investment from the very beginning made possible the introduction of quality products ahead of its competitors in most cases. Incepta Pharmaceuticals Ltd. is now the 2nd largest company of the country and recognized as the fastest growing of the top five manufacturing company in the country. Incepta now has one of the largest and competent sales force and large distribution network of its own, operated from 18 different locations throughout the country. A marketing team composed of pharmacists and doctors are at the core of the marketing operation. These professionals play a crucial role in providing the necessary strategic guideline for the promotion of its product. The company has very innovative plan to become a most renowned pharmaceutical company in the world by improving research based dosage form manufacturing within a very short period. ...
Words: 1959 - Pages: 8
...1.0 Introduction 1.1 Overview of Pharmaceutical Industry In Bangladesh Pharmaceuticals industry is the heart of the healthcare sector of Bangladesh. After liberation in 1971, the industry was largely dominated by MNCs, and the country was highly import dependent. In 1982, through the formulation of national drug policy, and drug control ordinance, a defined guideline for the development of the industry was created. One of the fastest growing sectors with an annual average growth rate consistently in the double digits, the Bangladesh Pharmaceutical industry contributes almost 1% to the nation’s GDP. According to the UKTI (April, 2010) the total size of the pharmaceutical market of Bangladesh was estimated to be US$700 million in 2007. The retail market is about 90% of the total market. In that respect, the total market size is more than BDT 60 billion.(Chowdhury, 2010) The industry produced medication worth $715 million in 2007 with the market growing over 12% annually over the last half a decade and firms primarily focus primary on branded generic final formulations by using mostly imported APIs. According to the World Bank report (2008) about 80% of the drugs sold in Bangladesh are generics and 20% are patented drugs. The country manufactures about 450 generic drugs for 5,300 registered brands which have 8,300 different forms of dosages and strengths. These include a wide range of products from anti-ulcerants, flouroquinolones, anti-rheumatic non-steroid drugs, non-narcotic...
Words: 2034 - Pages: 9
... Most Strategic Management Model There are several Strategic Models are available and used in different organizations but following are the most used strategic models: 1. PEST analysis 2. STEER Analysis 3. Five Forces Model 4. Strategic Group Map 5. SWOT analysis 6. Blue Ocean Strategies 7. Open innovation 8. McKinsey seven S model Company Detailed Profile including mission & vision and Organogram Company Detail Profile Square pharmaceutical is now the most leading company in Bangladesh since 1985 and is now on its way to becoming a high performance global player. Today it has achieved a state of mind among consumers. This company has founded in 1958 and since then with hard work and dedication among employees and top management, it has reached the position where every pharmaceutical company wants to reach. Square went public in 1991 and is currently listed on the Dhaka Stock Exchange and Chittagong Stock Exchange. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership...
Words: 5122 - Pages: 21
...14 3.1.3 OPPORTUNITIES: 14 3.1.4 THREATS: 15 3.2 Competitive Strategy Analysis: 16 3.2.1 Advantage of SPL in using an Integrated Strategy: 17 3.2.2 Disadvantages of SPL in using an Integrated Strategy: 17 CHAPTER 01: COMPANY OVERVIEW 1.1 Introduction The flagship company of the Square group of industries, Square Pharmaceuticals Limited (SPL) is the largest pharmaceuticals company in Bangladesh. Founded in 1958 and headquartered in Dhaka, Bangladesh, SPL develops, manufactures and markets drugs for humans and the animal world. The company owns and operates modern pharmaceutical factories mainly in Bangladesh and also has a separate division to operate a modern chemical factory which produces and sells basic chemical products. It also has divisions to produce and sell agrovet and pesticide products. It exports its products to Europe, Asia, Africa and South America. SQUARE Pharmaceuticals Limited (SPL) is the largest pharmaceutical company in Bangladesh and is leading the Pharmaceuticals sector from the very beginning. It has been continuously in the 1st position among all national and multinational companies since 1985. SPL offers a range of pharmaceutical products, which include alimentary preparations, anesthetics, antiallergy preparations, antidiabetic preparations, antihaemorrhagic, antiparasite preparations, aromatase...
Words: 3682 - Pages: 15
...TABLE OF CONTENTS: * Part one: Introduction A Brief Description of CSR 9 A Brief Description of CSR Practices by Bangladeshi Companies 10 A Description of Reporting Practices Including Reporting of CSR Activities 12 * Part Two: Statement of the Problem Emphasis on Business Involvement in CSR Activities 15 Theoretical Discussion on CSR Practices 19 Why The Reporting Necessary in relation to CSR Practices 22 Standard of Listed companies in Bangladesh with Regard to Social Audit 23 * Part Three: Objectives, Scope & Methodology of the Study Objectives 26 Scope 27 Methodology 28 * Part Four: Findings of the Study Sample Enterprises 30 Areas of Social Responsibilities Discharged 33 Reporting Practices 36 Evaluation 37 * Part Five: Conclusion Summary of the Findings 39 Future Directions 40 References 42 Part one: Introduction A Brief Description of CSR Corporate social responsibility (CSR), also known as corporate responsibility, corporate citizenship, responsible business, sustainable responsible business (SRB), or corporate social performance, is a form of corporate self-regulation integrated into a business model. Ideally, CSR policy would function as a built-in, self-regulating mechanism whereby business...
Words: 4961 - Pages: 20
...challenges, global production, globalization and its impact in business, research and development of SQUARE and Ethical issues involved in international business. As SQUARE is the top local pharmaceuticals company of Bangladesh so we have chosen it for our report so that we can have a wider view of our concern topics. Basically what we want to cover is the current export situation of the company, the problem that it is facing and solutions they are applying. Besides these we have also recommended some suggestions from our end which can be applied for the betterment of their export business. Objectives We have divided the objective of this report into two parts. One is general and the other is more specific. These objectives are stated below: ❖Primary objectives: Basically our initial objective was to complete the assigned task of term paper for the course of International Business. The topic with which we were assigned was identifying problems and solution of a particular company of export-import industry of Bangladesh. While completing this task firstly we have chosen SQUARE Pharmaceuticals Ltd. Bangladesh because it is the topmost local pharmaceuticals in our country. ❖Secondary objectives: Main focus of our report was to study the areas as follows: 1. To know about the SQUARE Pharmaceuticals Ltd. 2. To know about Export- Import trends and growth of SQUARE 3. To know about FDI Prospects and challenges in International Business. 4. To know about Strategic options for International...
Words: 5437 - Pages: 22
...Historical background Beximco Pharmaceuticals Limited (BPL) is a part of Beximco Group, the largest private sector industrial conglomerate in Bangladesh. BPL develops, manufactures and markets both finished dosage form branded generic pharmaceutical products and active pharmaceutical ingredients (APIs), with products including solid dose forms, Metered Dose Inhalers, Nasal Sprays, Large Volume Intravenous Fluids, Suppositories, and Creams/Ointments. BPL produces and markets 'branded generics' for most diseases ranging from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. The company also manufactures active pharmaceutical ingredients and intravenous fluids and contract manufacture for major international brands of leading multinational companies. BPL utilizes state of the art manufacturing facilities. BPL also has outstanding reverse engineering capabilities. Incorporated in 1976, BPL started off as a distributor of pharmaceutical products. It imported products from global MNCs such as Bayer AG of Germany and Upjohn Inc. of USA and sold them in the local market. It eventually graduated to a manufacturer and distributor of these products in local market under licensing agreements. During the early 80s, BPL launched its own products in the local market. Beximco started its exports operation in the early 90s with APIs. Today BPL is one of the largest exporters of medicines from Bangladesh. BPL employs more than 2,400...
Words: 1988 - Pages: 8
